Domestic simvastatin market getting heated

Published: 2003-02-13 06:59:00

Updated: 2003-02-13 06:59:00

With the incessant launchings of patent-expired simvastatin preparations, lipid-lowering agent, fierce competitions between domestic and foreign-invested pharmaceutical firms are being flared up.

Informed sources say that production of simvastatin preparations last year amounted to 70.0 billi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK